- Effects of the Use of Beta-Blockers on Chronic Obstructive Pulmonary Disease Associated with Cardiovascular Comorbities: Systematic Review and Meta-analysis
-
dos Santos NC, Camelier AA, Menezes AK, de Almeida VDC, Maciel RRBT, Camelier FWR
- KMID: 2556825
- Tuberc Respir Dis.
- 2024 Jul;87(3):261-281.
- doi: 10.4046/trd.2024.0013
Cardiovascular comorbidity is common in individuals with chronic obstructive pulmonary disease (COPD). This factor interferes with pharmacological treatment. The use of β-blockers has been proposed for their known cardioprotective effects.... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review
-
Santos NCd, Miravitlles M, Camelier AA, Almeida VDCd, Maciel RRBT, Camelier FWR
- KMID: 2531449
- Tuberc Respir Dis.
- 2022 Jul;85(3):205-220.
- doi: 10.4046/trd.2021.0179
This study aimed to describe the prevalence of comorbidities associated with chronic obstructive pulmonary disease (COPD) and their relation with relevant outcomes. A systematic review based on the PRISMA methodology... -
- CITED
-
- Close
- SHARE
-
- Close
